139 related articles for article (PubMed ID: 6136524)
1. Role of catecholamines in the ketonemic response to somatostatin in normal man.
Beaufrere B; Beylot M; Riou JP; Serusclat P; Cohen R; Souquet JC; Mornex R
J Clin Endocrinol Metab; 1983 Oct; 57(4):847-50. PubMed ID: 6136524
[TBL] [Abstract][Full Text] [Related]
2. Lack of beta-adrenergic role for catecholamines in the development of hyperglycemia and ketonaemia following acute insulin withdrawal in type I diabetic patients.
Beylot M; Sautot G; Dechaud H; Cohen R; Riou JP; Serusclat P; Mornex R
Diabete Metab; 1985 Apr; 11(2):111-7. PubMed ID: 2989015
[TBL] [Abstract][Full Text] [Related]
3. Effect of epinephrine and somatostatin-induced insulin deficiency on ketone body kinetics and lipolysis in man.
Weiss M; Keller U; Stauffacher W
Diabetes; 1984 Aug; 33(8):738-44. PubMed ID: 6146545
[TBL] [Abstract][Full Text] [Related]
4. Regulation of glucose turnover during exercise in pancreatectomized, totally insulin-deficient dogs. Effects of beta-adrenergic blockade.
Bjorkman O; Miles P; Wasserman D; Lickley L; Vranic M
J Clin Invest; 1988 Jun; 81(6):1759-67. PubMed ID: 3290252
[TBL] [Abstract][Full Text] [Related]
5. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia.
Rizza RA; Cryer PE; Gerich JE
J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413
[TBL] [Abstract][Full Text] [Related]
6. Catecholamines in prevention of hypoglycemia during exercise in humans.
Marker JC; Hirsch IB; Smith LJ; Parvin CA; Holloszy JO; Cryer PE
Am J Physiol; 1991 May; 260(5 Pt 1):E705-12. PubMed ID: 1674642
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of physiological versus pathophysiological plasma concentrations of epinephrine and norepinephrine on ketone body metabolism and hepatic portal blood flow in man.
Krentz AJ; Freedman D; Greene R; McKinley M; Boyle PJ; Schade DS
Metabolism; 1996 Oct; 45(10):1214-20. PubMed ID: 8843175
[TBL] [Abstract][Full Text] [Related]
8. Regulation of ketogenesis by epinephrine and norepinephrine in the overnight-fasted, conscious dog.
Steiner KE; Fuchs H; Williams PE; Stevenson RW; Cherrington AD; Alberti KG
Diabetes; 1985 May; 34(5):425-32. PubMed ID: 3886459
[TBL] [Abstract][Full Text] [Related]
9. Regulation of somatostatin secretion in man: study of the role of free fatty acids and ketone bodies.
Beylot M; Chayvialle JA; Riou JP; Souquet JC; Sautot G; Cohen R; Mornex R
Metabolism; 1984 Nov; 33(11):988-93. PubMed ID: 6149447
[TBL] [Abstract][Full Text] [Related]
10. Epinephrine and norepinephrine are cleared through beta-adrenergic, but not alpha-adrenergic, mechanisms in man.
Cryer PE; Rizza RA; Haymond MW; Gerich JE
Metabolism; 1980 Nov; 29(11 Suppl 1):1114-8. PubMed ID: 6107816
[TBL] [Abstract][Full Text] [Related]
11. Adrenergic effects on plasma levels of glucagon, insulin, glucose and free fatty acids in rabbits.
Knudtzon J
Horm Metab Res; 1984 Aug; 16(8):415-22. PubMed ID: 6381275
[TBL] [Abstract][Full Text] [Related]
12. [Metabolic risks of salbutamol in diabetic patients. A study using somatostatin (author's transl)].
Schlienger JL; Compagnie MJ; Dellenbach P; Stephan F
Nouv Presse Med; 1980 Sep; 9(32):2247-51. PubMed ID: 6106923
[TBL] [Abstract][Full Text] [Related]
13. Adrenergic modulation of human pancreatic polypeptide (hPP) release.
Sive AA; Vinik AI; Levitt N
Gastroenterology; 1980 Oct; 79(4):665-72. PubMed ID: 6997131
[TBL] [Abstract][Full Text] [Related]
14. Role of glucagon in enhancing ketone body production in ketotic diabetic man.
Keller U; Schnell H; Sonnenberg GE; Gerber PP; Stauffacher W
Diabetes; 1983 May; 32(5):387-91. PubMed ID: 6132846
[TBL] [Abstract][Full Text] [Related]
15. Effects of somatostatin and adrenergic blockade on glucagon, insulin and glucose in exercising sheep.
Brockman RP; Halvorson R
Aust J Biol Sci; 1981; 34(5-6):551-60. PubMed ID: 6122438
[TBL] [Abstract][Full Text] [Related]
16. Atrial natriuretic peptide stimulates lipid mobilization during repeated bouts of endurance exercise.
Moro C; Polak J; Hejnova J; Klimcakova E; Crampes F; Stich V; Lafontan M; Berlan M
Am J Physiol Endocrinol Metab; 2006 May; 290(5):E864-9. PubMed ID: 16291573
[TBL] [Abstract][Full Text] [Related]
17. Regulation of human lipolysis. In vivo observations on the role of adrenergic receptors.
Burns TW; Mohs JM; Langley PE; Yawn R; Chase GR
J Clin Invest; 1974 Jan; 53(1):338-41. PubMed ID: 4808646
[TBL] [Abstract][Full Text] [Related]
18. Metabolic effects of cortisol in man--studies with somatostatin.
Johnston DG; Gill A; Orskov H; Batstone GF; Alberti KG
Metabolism; 1982 Apr; 31(4):312-7. PubMed ID: 6123062
[TBL] [Abstract][Full Text] [Related]
19. Adrenergic mechanisms for the effects of epinephrine on glucose production and clearance in man.
Rizza RA; Cryer PE; Haymond MW; Gerich JE
J Clin Invest; 1980 Mar; 65(3):682-9. PubMed ID: 6243675
[TBL] [Abstract][Full Text] [Related]
20. Metabolic effects of adrenaline and noradrenaline in man: studies with somatostatin.
Pernet A; Walker M; Gill GV; Orskov H; Alberti KG; Johnston DG
Diabete Metab; 1984 May; 10(2):98-105. PubMed ID: 6146542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
